Sort
326,823 grants matching “clinical trial”
TARGETED CLINICAL TRIALS TO REDUCE THE RISK OF ANTIMICROBIAL RESISTANCE
$8,509,190Keith Kaye · University Of Michigan At Ann Arbor · N01 · FY2017 · AI
ASPirin in Reducing Events in the Elderly - eXTension
$8,509,004Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2021 · AG
Clinical and Translational Science Institute
$8,507,126Vanessa Jacoby · University Of California, San Francisco · UL1 · FY2025 · TR
Extension of Combination Therapy for Multiple Sclerosis (eCombiRx)
$8,500,000Fred D Lublin · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · NS
CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT
$8,500,000Claudia Valmonte · The Emmes Company, Llc · N01 · FY2025 · CA
DRCR Network
$8,500,000Adam R Glassman · Jaeb Center For Health Research, Inc. · UG1 · FY2019 · EY
DRCR Network
$8,500,000Adam R Glassman · Jaeb Center For Health Research, Inc. · UG1 · FY2020 · EY
Extension of Combination Therapy for Multiple Sclerosis
$8,500,000Fred D Lublin · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · NS
Alzheimer's Disease Neuroimaging Initiative
$8,500,000Northern California Institute Res &Educ · U01 · FY2005 · AG
THE GULF WAR ILLNESS CLINICAL TRIALS AND INTERVENTIONS CONSORTIUM (GWICTIC)
$8,500,000Nova Southeastern University, Inc · · FY2018 · Defense Health Agency
Clinical and Translational Science Institute
$8,497,502Vanessa Jacoby · University Of California, San Francisco · UL1 · FY2024 · TR
Statistical and Data Coordinating Center
$8,495,301Marian Ewell · The Emmes Company, Llc · N01 · FY2012 · AI
BEMPEDOIC ACID THERAPY FOR POLYCYSTIC KIDNEY DISEASE (BEAT-PKD) RANDOMIZED CLINICAL TRIAL
$8,491,997University Of Vermont & State Agricultural College · · FY2025 · Defense Health Agency
caBIG pilot
$8,491,311Kenneth Buetow · Basic Sciences · Z01 · FY2007 · CA
ASPirin in Reducing Events in the Elderly
$8,485,338Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2015 · AG
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies
$8,479,107Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2023 · AG
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTG
$8,477,926David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2011 · AI
DEVELOPMENT OF AN ORAL DRUG FOR SMALLPOX TREATMENT
$8,477,202Chimerix, Inc. · U01 · FY2005 · AI
Clinical and Translational Science Institute
$8,476,672Vanessa Jacoby · University Of California, San Francisco · UL1 · FY2023 · TR
HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy
$8,473,830Deborah J Donnell · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
caBIG Enterprise
$8,466,521Kenneth Buetow · Office Of The Director, Nci · ZIH · FY2009 · CA
PEDIATRIC ONCOLOGY GROUP
$8,465,596National Childhood Cancer Foundation · U10 · FY2001 · CA
NIDA Clinical Trials Network: New York Node
$8,461,097John P Rotrosen · New York University School Of Medicine · UG1 · FY2020 · DA
Spectrum Stanford Center for clinical and Translational Research and Education
$8,460,470Harry Bernard Greenberg · Stanford University · UL1 · FY2014 · TR
HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)
$8,460,011Bambra Stokes · Ppd Development Lp · N01 · FY2024 · AI